A carregar...
Aripiprazole added to Overweight and Obese Olanzapine-treated Schizophrenia Patients
Olanzapine treatment has been associated with clinically meaningful weight increases, hypertriglyceridemia, insulin resistance and diabetes mellitus. There are few options for olanzapine-responders who fail other antipsychotic agents. Aripiprazole is a potent (high-affinity) partial agonist at D2 an...
Na minha lista:
| Publicado no: | J Clin Psychopharmacol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4311767/ https://ncbi.nlm.nih.gov/pubmed/19512978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0b013e31819a8dbe |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|